Novacyt (ALNOV) — Capital Reinvestment Ratio
Latest as of December 2021:
0.07x
Novacyt (ALNOV) has a Capital Reinvestment Ratio of 0.07x as of December 2021, meaning it reinvests 0% of its operating cash flow (€16.56 Million) in capital expenditures (€1.10 Million). See ALNOV FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
€16.56 Million
EUR
Capital Expenditures
€1.10 Million
EUR
Data as of
Dec 2021
Most recent filing
Novacyt Capital Reinvestment Ratio (2010–2021)
This chart tracks Novacyt's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Novacyt (2010–2021)
Year-by-year Capital Reinvestment Ratio for Novacyt from 2010 to 2021. For live market cap and broader valuation context, see Novacyt stock valuation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.26x | €15.69 Million | €4.10 Million | ▲ +2178.6% |
| 2020 | 0.01x | €102.98 Million | €1.18 Million | ▼ -99.8% |
| 2010 | 4.65x | €34.00K | €158.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow